Production (Stage)
HCW Biologics Inc.
HCWB
$5.22
-$0.27-4.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -72.88% | 30.03% | -91.10% | -93.33% | -85.54% |
| Total Receivables | -90.32% | -62.09% | -8.21% | -7.38% | 257.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -67.28% | -68.51% | -79.56% | -70.15% | -30.84% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.37% | -50.84% | -49.63% | -49.68% | 37.95% |
| Total Current Assets | -69.48% | -11.02% | -84.88% | -87.95% | -79.26% |
|
|
|||||
| Total Current Assets | -69.48% | -11.02% | -84.88% | -87.95% | -79.26% |
| Net Property, Plant & Equipment | 0.76% | 12.01% | 53.76% | 79.10% | 89.96% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -49.56% | -99.46% | -99.47% | -72.14% |
| Total Assets | -13.61% | 6.04% | -25.44% | -32.07% | -30.11% |
|
|
|||||
| Total Accounts Payable | 88.06% | 262.11% | 618.69% | 697.54% | 801.03% |
| Total Accrued Expenses | -59.79% | -59.64% | -50.14% | 181.01% | 27.27% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -33.09% | -40.70% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 102.36% | 238.71% | 455.01% | 411.67% | 196.61% |
|
|
|||||
| Total Current Liabilities | 102.36% | 238.71% | 455.01% | 411.67% | 196.61% |
| Long-Term Debt | -6.88% | 17.03% | 2.05% | 55.68% | 29.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 60.68% | 145.86% | 210.88% | 203.92% | 98.68% |
|
|
|||||
| Common Stock & APIC | 8.59% | 11.66% | 4.17% | 4.17% | 4.22% |
| Retained Earnings | -31.73% | -42.57% | -62.37% | -69.87% | -54.12% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -197.96% | -150.29% | -141.77% | -122.04% | -73.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -197.96% | -150.29% | -141.77% | -122.04% | -73.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -197.96% | -150.29% | -141.77% | -122.04% | -73.20% |
|
|
|||||